tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:ECQ0 Stock Latest News

Neurizon Publishes General Meeting Results and Enhances Investor Engagement
Company AnnouncementsNeurizon Publishes General Meeting Results and Enhances Investor Engagement
2d ago
Neurizon Therapeutics Issues Heavily Qualified General Meeting Presentation
PremiumCompany Announcements
Neurizon Therapeutics Issues Heavily Qualified General Meeting Presentation
2d ago
Neurizon Therapeutics Director Marcus Hughes Increases Shareholding
PremiumCompany Announcements
Neurizon Therapeutics Director Marcus Hughes Increases Shareholding
19d ago
Neurizon Secures FDA Green Light and Full Funding for Late-Stage NUZ-001 ALS Trial
PremiumCompany Announcements
Neurizon Secures FDA Green Light and Full Funding for Late-Stage NUZ-001 ALS Trial
23d ago
Neurizon Secures A$6m R&D Tax Rebate to Fund HEALEY ALS Trial
PremiumCompany Announcements
Neurizon Secures A$6m R&D Tax Rebate to Fund HEALEY ALS Trial
24d ago
Neurizon Therapeutics Seeks ASX Quotation for 73.5 Million New Shares
PremiumCompany AnnouncementsNeurizon Therapeutics Seeks ASX Quotation for 73.5 Million New Shares
24d ago
Neurizon Raises $5.9m in Entitlement Offer to Advance ALS Trial
Premium
Company Announcements
Neurizon Raises $5.9m in Entitlement Offer to Advance ALS Trial
26d ago
Neurizon Therapeutics Updates Market on Director Michael Thurn’s Revised Securities Holdings
Premium
Company Announcements
Neurizon Therapeutics Updates Market on Director Michael Thurn’s Revised Securities Holdings
30d ago
Neurizon Calls Virtual-Only General Meeting as It Shifts to Digital Shareholder Communications
PremiumCompany Announcements
Neurizon Calls Virtual-Only General Meeting as It Shifts to Digital Shareholder Communications
1M ago
Neurizon Locks In Global Trademark Protection for NEURIZON Brand Across Key Pharma Markets
PremiumCompany Announcements
Neurizon Locks In Global Trademark Protection for NEURIZON Brand Across Key Pharma Markets
1M ago
Neurizon Sets Out 2026 Execution Plan Ahead of HEALEY ALS Trial Enrolment
PremiumCompany Announcements
Neurizon Sets Out 2026 Execution Plan Ahead of HEALEY ALS Trial Enrolment
1M ago
Neurizon to Host Investor Webinar on Funding and HEALEY ALS Trial Milestones
PremiumCompany Announcements
Neurizon to Host Investor Webinar on Funding and HEALEY ALS Trial Milestones
1M ago
Neurizon Therapeutics Options Lapse, Trimming Potential Future Dilution
PremiumCompany AnnouncementsNeurizon Therapeutics Options Lapse, Trimming Potential Future Dilution
2M ago
Neurizon Opens A$17.1m Entitlement Offer to Fund Neurodegenerative Pipeline
Premium
Company Announcements
Neurizon Opens A$17.1m Entitlement Offer to Fund Neurodegenerative Pipeline
2M ago
Neurizon Clears Secondary Trading for $6.3m Share Placement
Premium
Company Announcements
Neurizon Clears Secondary Trading for $6.3m Share Placement
2M ago
Neurizon Maps Regulatory Pathway as NUZ-001 Advances in HEALEY ALS Trial
PremiumCompany Announcements
Neurizon Maps Regulatory Pathway as NUZ-001 Advances in HEALEY ALS Trial
2M ago
Neurizon Director Increases Stake Through Participation in Share Placement
PremiumCompany Announcements
Neurizon Director Increases Stake Through Participation in Share Placement
2M ago
Neurizon Therapeutics Seeks ASX Quotation for 79.3 Million New Shares
PremiumCompany Announcements
Neurizon Therapeutics Seeks ASX Quotation for 79.3 Million New Shares
2M ago
Neurizon Issues Director Shares Under Cleansing Notice After September Placement
PremiumCompany Announcements
Neurizon Issues Director Shares Under Cleansing Notice After September Placement
2M ago
Neurizon Therapeutics Launches $17.1m Pro-Rata Entitlement Offer
PremiumCompany AnnouncementsNeurizon Therapeutics Launches $17.1m Pro-Rata Entitlement Offer
2M ago
Neurizon Therapeutics Plans Convertible Note and Share Placement to Fund Growth
Premium
Company Announcements
Neurizon Therapeutics Plans Convertible Note and Share Placement to Fund Growth
2M ago
Neurizon Therapeutics Plans Major Equity Raising via Pro Rata Issue and Placement
Premium
Company Announcements
Neurizon Therapeutics Plans Major Equity Raising via Pro Rata Issue and Placement
2M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >